Privia Health Group, Inc. Stock Price, News & Analysis

Privia Health (Nasdaq: PRVA) reported strong Q2 2025 financial results, with significant growth across key metrics. Total revenue increased 23.4% to $521.2 million, while Practice Collections grew 18.5% to $862.9 million. The company achieved Adjusted EBITDA of $29.0 million, up 31.6% year-over-year.

Notable operational highlights include a 13.8% increase in Implemented Providers to 5,125 and a 15.2% growth in Value-Based Care Attributed Lives to 1.38 million. Following the IMS transaction in Arizona, Privia maintains a strong balance sheet with $390.1 million in cash and no debt.

Based on strong performance, Privia raised its FY2025 guidance above the high end of previous ranges for Practice Collections, GAAP Revenue, Platform Contribution, and Adjusted EBITDA.

Privia Health (Nasdaq: PRVA) has scheduled its second quarter and six-month 2025 financial results announcement for Thursday, August 7, 2025, before market open. The company will release its earnings press release by 7:00 am ET.

Management will host a conference call at 8:00 am ET on the same day to discuss results and future outlook. Investors can access the live webcast through the company's IR website, with replay available after the call. For those joining by phone, the dial-in numbers are 888-596-4144 (domestic) or 646-968-2525 (international) with Conference ID 5704885.

Privia Health (Nasdaq: PRVA) has appointed Lance V. Berberian to its Board of Directors, effective July 15, 2025. Berberian, who will also serve on the Board's Audit Committee, brings over 30 years of technology expertise to the now 10-member board.

Berberian's most recent role was EVP and Chief Information and Technology Officer at Labcorp Holdings, where he led a 5,000-person team focused on IT strategy, cybersecurity, AI, product development, and data management from 2014 to 2024. His prior experience includes CIO positions at IDEXX Laboratories, Kellstrom Aerospace, Interim HealthCare, and Quest Diagnostics.

Privia Health (NASDAQ: PRVA) reported strong Q1 2025 financial results with significant growth across key metrics. Total revenue increased 15.6% to $480.1M, while operating income surged 534% to $5.2M. The company saw net income grow 41.4% to $4.2M. Key operational metrics showed robust performance with Practice Collections up 12.8% to $798.6M and Adjusted EBITDA rising 35.1% to $26.9M. Privia expanded into Arizona through a $95M acquisition of Integrated Medical Services, adding approximately 70 healthcare providers. The company raised its FY2025 guidance to the mid-to-high end of most metrics, maintaining strong growth momentum while expecting minimal increase in value-based shared savings accruals.

Privia Health Group (PRVA) has announced its expansion into Arizona through a partnership with Integrated Medical Services (IMS), marking its entry into its 15th state. IMS, one of Arizona's largest independent multi-specialty practices, brings approximately 70 physicians and advanced practice providers across 21 locations, managing over 28,000 attributed lives across various value-based care arrangements.

The partnership will establish Privia Medical Group—Arizona, with IMS serving as the anchor practice while maintaining physician ownership and operation. Implementation on the Privia Platform is scheduled for Q4 2025, with profitability expected in the same quarter and throughout 2026.

IMS currently serves patients through Commercial, Medicare, Medicare Advantage, and Medicaid programs. The collaboration aims to provide independent providers across Arizona with new alternatives for patient care, regardless of reimbursement models.

Privia Health Group (Nasdaq: PRVA) has scheduled the release of its first quarter 2025 financial results for Thursday, May 8, 2025, before market open. The results announcement is planned for 7:00 am ET and will be available on the company's Investor Relations website.

Management will host a conference call at 8:00 am ET on the same day to discuss Q1 2025 results and provide insights on future financial and operational performance outlook. Investors can access the live webcast through the company's IR website, with an archived version available for replay after the call. For direct participation, attendees can dial 888-596-4144 (US) or 646-968-2525 (international) using Conference ID 5704885.

Privia Health (PRVA) reported strong financial results for Q4 and full-year 2024, exceeding all operating and financial metrics guidance ranges. Key highlights include:

- Implemented Providers grew 11.2% from 2023
- Fee-for-service collections increased 13.6% year-over-year
- Medicare Shared Savings Program (MSSP) generated $176.6M in savings, up 34.1% from 2022
- Adjusted EBITDA grew 25.2% compared to 2023
- Net Cash from Operations reached $109.3M, increasing 35.3% from 2023
- Free Cash Flow of $109.3M, representing 121% of Adjusted EBITDA

The company ended 2024 with a strong balance sheet showing $491.1M in cash and no debt, up 26.1% from $389.5M in 2023. For 2025, Privia expects continued momentum despite challenging Medicare Advantage market conditions.

Privia Health Group (Nasdaq: PRVA) has announced it will release its fourth quarter and full-year 2024 financial results before market open on Thursday, February 27, 2025. The press release will be disseminated by 7:00 am ET and will be available on the company's Investor Relations website.

Management will host a conference call at 8:00 am ET on the same day to discuss results and provide outlook on future financial and operational performance. Investors can access the live webcast through the company's IR website, with an archived version available for replay after the call. For those joining by phone, the dial-in number is 646-968-2525 (888-596-4144 for international callers) with Conference ID 5704885.

Privia Health (NASDAQ: PRVA) reported strong Q3 2024 financial results with total revenue increasing 4.9% to $437.9 million. The company showed significant growth across key metrics, with Adjusted EBITDA rising 25.8% to $23.6 million. Implemented providers grew 13.1% to 4,642, while value-based care attributed lives increased 14.0% to 1.247 million. The company's ACOs achieved $176.6 million in MSSP shared savings, up 34.1% from 2022. Privia maintains a strong financial position with $422.0 million in cash and no debt. Based on performance, the company raised its full-year 2024 guidance to at or above the high end for all metrics.